checkAd
    Startseite > Aktien > Elite Pharmaceuticals > Nachrichten
    Elite Pharmaceuticals Aktie
    0,1263
     
    USD
    +2,93 %
    +0,0036 USD
    Letzter Kurs 02:10:00 Nasdaq OTC
    ISIN: US28659T2006 · WKN: 634826 · SYM: ELTP · USA

    Neueste Nachrichten

    Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLC
    12.12.23 · Accesswire · Elite Pharmaceuticals
    Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Information
    14.11.23 · Accesswire · Elite Pharmaceuticals
    Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2024 Financial Results on November 15, 2023
    10.11.23 · Accesswire · Elite Pharmaceuticals
    Elite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Product
    25.09.23 · Accesswire · Elite Pharmaceuticals
    Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
    07.09.23 · Accesswire · Elite Pharmaceuticals
    Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
    28.08.23 · Accesswire · Elite Pharmaceuticals
    Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023
    09.08.23 · Accesswire · Elite Pharmaceuticals
    Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information
    29.06.23 · Accesswire · Elite Pharmaceuticals
    Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023
    22.06.23 · Accesswire · Elite Pharmaceuticals
    Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer
    03.05.23 · Accesswire · Elite Pharmaceuticals